Read More Pharma Industry News QIAGEN files lawsuit against bioMĂ©rieux to defend QuantiFERON patents and innovation in TB diagnostics QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has initiated legal proceedings against bioMĂ©rieux S.A. (EPA: BIM) in… byPallavi MadhirajuMarch 3, 2025